HealthEquity Inc - HQY Total Company Value-to-Revenue Ratio

Official company branding of healthequity.com (HQY)

HealthEquity, Inc. (HQY) faces risks related to the ESG agenda, which the company is addressing through a total transition to digital document management. The current EV/Sales trend on the GURU.Markets dynamic chart, where 6439.18 represents the latest level, confirms stability. This is supported by the low cyclicality of HSA accounts and a robust ecosystem of employers whose contribution limits are regulated by IRS norms.

HQY (HealthEquity) Company Value to Revenue history from 11/23/2025 to 11/20/2026

HealthEquity Building - analytical breakdowns and key metrics (HQY)

- current quotes and average value forecast:
Initial company analysis:HealthEquity, Inc., HQY
Product sample of HealthEquity Corp

This indicator determines the market value of the business accounting for net debt relative to sales volume, allowing for an assessment of the asset's overvaluation without distortions from the financing structure. By analyzing the EV/Revenue ratio on GURU.Markets, an investor can compare the expansion rates of HSA accounts and the interest income of HealthEquity, Inc. (HQY) with price action to identify fundamental price overheating in a timely manner.

Competitor analysis for HealthEquity, Inc.

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple Waystar Health (WAY)|Enterprise Value-to-Revenue Ratio CorVel Healthcare|EV/Sales Multiple Privia Medical Group|Company Value to Revenue HURN (Huron Corp)|Company Value to Revenue Certara CERT|EV/Sales Multiple OMCL (Omnicell Inc)|Total Company Value-to-Revenue Ratio GoodRx Inc (GDRX)|Schrodinger Corp - EV/Sales Multiple|Enterprise Value to Sales Volume PHR|OMDA: EV/Sales Multiple|Evolent Health, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio HealthStream Corp|DH: Business Value to Revenue|Company Value to Revenue CCSI (Consensus)|Total Company Value-to-Revenue Ratio Agilon Health|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)